HD12 for Advanced Stages

This study is designed to test (1) whether the BEACOPP dosage can be reduced to baseline in the last 4 cycles without loss of effectiveness, and (2) whether consolidating irradiation is necessary foll...

Lead sponsor: University of Cologne•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDNA

Music & Cancer - Live Music During Chemotherapy

NCT01870479 · Non Hodgkin´s Lymphomas, Hodgkin´s Lymphomas

COMPLETEDPhase 3

HD11 for Intermediate Stages

NCT00264953 · Hodgkin´s Lymphoma

COMPLETEDPhase 3

HD10 for Early Stages

NCT00265018 · Hodgkin´s Lymphoma

COMPLETEDPhase 2

Rituximab in Primary Lymphocyte Predominant Hodgkin´s Disease(RIPL)

NCT00346684 · Lymphocyte Predominant Hodgkin´s Lymphoma (LPHD)

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 25, 2012Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment—

Start dateJan 1999

Last updatedJun 25, 2012

Condition

Hodgkin´s Lymphoma

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 25, 2012Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions